I took part in this survey recently, and was asked if I would mind sharing with others! A patient centred research team are doing research in the form of online 1:1 interviews for a pharmaceutical company. They are currently looking for males who have switched from taking Intravenous (IV) Ocrevus for Multiple Sclerosis to Ocrevus subcutaneous injection treatment to learn about their experiences on both treatment modes and their experience switching. The purpose of the research is to gain an understanding of patients’ experiences with both treatment methods, including their reasons for switching, their experience of the transition, and their overall perspective about the two methods of administration. We are keen to hear directly from patients and provide them with an opportunity to share their experiences and insights to help inform future research and understanding of MS treatment experiences. Participation involves an anonymous 60-minute one-on-one interview conducted via a digital platform. There are no study drugs or procedures administered as part of this study. The compensation is £100 pounds, payable by either Amazon vouchers or PayPal, following completion of the interview. To register, people can sign up via the link: https://survey.opinionhealth.co.uk/uc/19026AN/?a=1&b=AN&c=Johnathan&d=